Ligand and structure-based virtual screening approaches in drug discovery: minireview-Reference-Cited by-同舟云学术

Ligand and structure-based virtual screening approaches in drug discovery: minireview

Published:2024-09-02 Issue: Volume: Page:
ISSN:1381-1991
Container-title:Molecular Diversity
language:en
Short-container-title:Mol Divers

Author:

da Rocha Matheus Nunes,de Sousa Damião Sampaio,da Silva Mendes Francisco Rogenio,dos Santos Helcio Silva,Marinho Gabrielle Silva,Marinho Márcia Machado,Marinho Emmanuel Silva

Funder

Fundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11030-024-10979-6.pdf

Reference67 articles.

1. De Sousa Luis JA, Da Silva Souza HD, Lira BF, Da Silva AF, De Athayde-Filho PF, De Souza Lima TK et al (2019) Combined structure- and ligand-based virtual screening aiding discovery of selenoglycolicamides as potential multitarget agents against Leishmania species. J Mol Struct 1198:126872. https://doi.org/10.1016/j.molstruc.2019.126872

2. Song Z, Yin F, Xiang B, Lan B, Cheng S (2018) Systems pharmacological approach to investigate the mechanism of Acori Tatarinowii Rhizoma for Alzheimer’s disease. Evid Based Complement Altern Med 2018:1–20. https://doi.org/10.1155/2018/5194016

3. De Azevedo W Jr, Dias R (2008) Computational methods for calculation of ligand-binding affinity. Curr Drug Targets 9:1031–1039. https://doi.org/10.2174/138945008786949405

4. Das A, SwamyPurawargaMatada G, Sanjay Dhiwar P, ManjunathaiahRaghavendra N, Abbas N, Singh E et al (2023) Molecular recognition of some novel mTOR kinase inhibitors to develop anticancer leads by drug-likeness, molecular docking and molecular dynamics based virtual screening strategy. Comput Toxicol 25:100257. https://doi.org/10.1016/j.comtox.2022.100257

5. van de Waterbeemd H, Gifford E (2003) ADMET in silico modelling: towards prediction paradise? Nat Rev Drug Discov 2:192–204. https://doi.org/10.1038/nrd1032